Welcome to Shaping Tomorrow

Our Scans · (ZY.5.00) Covid-19 · Weekly Summary


  • [New] Economic development: Once among Asia's fastest-growing economies, Bangladesh has struggled since COVID-19 and the disruption of its export-driven garments sector during the 2024 unrest. The Indian Express
  • [New] A pregnant woman in Maryland seeing an OB-GYN affiliated with a major academic medical center will likely receive flu and COVID-19 vaccine recommendations this fall. CIDRAP
  • [New] In a separate development the UK biotech ILC Therapeutics said it has discovered two novel treatments that could be used in COVID-19 patients before they are put on ventilators. Pharmaphorum
  • [New] Routine childhood immunization rates in both Guatemala and Belize declined during the COVID-19 pandemic, potentially increasing the risk for vaccine-preventable infections such as measles and pertussis. Yellow Book
  • The lackluster revenue outlook comes in part from declining sales of its Covid vaccine and Paxlovid, which it expects to fall by $1.5 billion year over year to $5 billion. CNBC
  • Global crises like the COVID-19 pandemic, climate change, economic shocks and social justice movements have exposed vulnerabilities in sports' traditional models. PubMed Central (PMC)
  • The COVID-19 pandemic fundamentally reshaped the context for quantum strategy development due to heightened concerns about technological resilience and supply chain vulnerabilities. RBC WEALTH MANAGEMENT
  • While AI may be claiming the spotlight, investment across supply chain technology will increase in 2026 - although not at as high a pace as during the COVID era. DC Velocity
  • Maryland will continue to work with partners to address the availability of COVID-19 vaccine for children. Maryland.gov Enterprise Agency Template
  • The structural vulnerability and social invisibility frameworks are evident in global crises like COVID-19 and climate change, which highlight how uncertainty and vulnerability combine to disadvantage marginalized groups. SpringerLink
  • 8.6% of adults 18 years and older, 12.5% of adults 18-64 years with high-risk conditions, and 10.0% of adults 65 years and older reported that they definitely will get vaccinated with a 2025-26 COVID-19 vaccine. / USA RespVaxView
  • RBC Capital says it still has confidence in Moderna's cancer vaccine and its long-term potential, but challenges like declining COVID demand and slow RSV uptake remain in the short term. Benzinga
  • The FDA approved an investigational new drug application from Ocugen Inc for a nasal COVID-19 vaccine that will begin a Phase 1 clinical trial. Respiratory Therapy
  • As viral trends on Instagram and YouTube push dangerous miracle diets, a new study exposes how misinformation worsens orthorexia and COVID-19 risks - and why doctors are urging a social media shakeup to save lives. News-Medical
  • The Sarawak government, under the Post-Covid-19 Development Strategy 2030, had made a strong commitment to sustainable development. Borneo Post Online
  • Novavax, which produces a protein-based COVID-19 vaccine and requires a longer process compared with the mRNA capabilities of Pfizer and Moderna, could face obstacles to producing an updated vaccine targeting LP. Pharmacy Times

Last updated: 20 June 2026



Please stand by...

The magic is happening, but it might take a couple of minutes.

Login